• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[通过不同生物信息学流程对肠易激综合征患者肠道微生物群组成分析的比较]

[Comparison of gut microbiotal compositional analysis of patients with irritable bowel syndrome through different bioinformatics pipelines].

作者信息

Zhu S W, Liu Z J, Li M, Zhu H Q, Duan L P

机构信息

Department of Gastroenterology, Peking University Third Hospital, Beijing 100191, China.

Department of Biomedical Engineering, College of Engineering, Peking University, Beijing 100187, China.

出版信息

Beijing Da Xue Xue Bao Yi Xue Ban. 2018 Apr 18;50(2):231-238.

PMID:29643520
Abstract

OBJECTIVE

To assess whether the same biological conclusion, diagnostic or curative effects regarding microbial composition of irritable bowel syndrome (IBS) patients could be reached through different bioinformatics pipelines, we used two common bioinformatics pipelines (Uparse V2.0 and Mothur V1.39.5)to analyze the same fecal microbial 16S rRNA high-throughput sequencing data.

METHODS

The two pipelines were used to analyze the diversity and richness of fecal microbial 16S rRNA high-throughput sequencing data of 27 samples, including 9 healthy controls (HC group), 9 diarrhea IBS patients before (IBS group) and after Rifaximin treatment (IBS-treatment, IBSt group). Analyses such as microbial diversity, principal co-ordinates analysis (PCoA), nonmetric multidimensional scaling (NMDS) and linear discriminant analysis effect size (LEfSe) were used to find out the microbial differences among HC group vs. IBS group and IBS group vs. IBSt group.

RESULTS

(1) Microbial composition comparison of the 27 samples in the two pipelines showed significant variations at both family and genera levels while no significant variations at phylum level; (2) There was no significant difference in the comparison of HC vs. IBS or IBS vs. IBSt (Uparse: HC vs. IBS, F=0.98, P=0.445; IBS vs. IBSt, F=0.47,P=0.926; Mothur: HC vs.IBS, F=0.82, P=0.646; IBS vs. IBSt, F=0.37, P=0.961). The Shannon index was significantly decreased in IBSt; (3) Both workshops distinguished the significantly enriched genera between HC and IBS groups. For example, Nitrosomonas and Paraprevotella increased while Pseudoalteromonadaceae and Anaerotruncus decreased in HC group through Uparse pipeline, nevertheless Roseburia 62 increased while Butyricicoccus and Moraxellaceae decreased in HC group through Mothur pipeline.Only Uparse pipeline could pick out significant genera between IBS and IBSt, such as Pseudobutyricibrio, Clostridiaceae 1 and Clostridiumsensustricto 1.

CONCLUSION

There were taxonomic and phylogenetic diversity differences between the two pipelines, Mothur can get more taxonomic details because the count number of each taxonomic level is higher. Both pipelines could distinguish the significantly enriched genera between HC and IBS groups, but Uparse was more capable to identity the difference between IBS and IBSt groups. To increase the reproducibility and reliability and to retain the consistency among similar studies, it is very important to consider the impact on different pipelines.

摘要

目的

为了评估对于肠易激综合征(IBS)患者微生物组成,能否通过不同的生物信息学流程得出相同的生物学结论、诊断或治疗效果,我们使用了两种常见的生物信息学流程(Uparse V2.0和Mothur V1.39.5)来分析相同的粪便微生物16S rRNA高通量测序数据。

方法

使用这两种流程分析27个样本的粪便微生物16S rRNA高通量测序数据的多样性和丰富度,其中包括9名健康对照者(HC组)、9名腹泻型IBS患者(IBS组)以及利福昔明治疗后的患者(IBS治疗组,IBSt组)。采用微生物多样性分析、主坐标分析(PCoA)、非度量多维尺度分析(NMDS)以及线性判别分析效应大小(LEfSe)等分析方法,找出HC组与IBS组以及IBS组与IBSt组之间的微生物差异。

结果

(1)两种流程对27个样本的微生物组成比较显示,在科和属水平存在显著差异,而在门水平无显著差异;(2)HC组与IBS组或IBS组与IBSt组的比较中无显著差异(Uparse:HC组与IBS组,F = 0.98,P = 0.445;IBS组与IBSt组,F = 0.47,P = 0.926;Mothur:HC组与IBS组,F = 0.82,P = 0.646;IBS组与IBSt组,F = 0.37,P = 0.961)。IBSt组的香农指数显著降低;(3)两种流程均能区分HC组和IBS组中显著富集的属。例如,通过Uparse流程,HC组中硝化单胞菌属和副普雷沃菌属增加,而假交替单胞菌科和厌氧短杆菌属减少;通过Mothur流程,HC组中罗斯氏菌属增加,而丁酸球菌属和莫拉菌科减少。只有Uparse流程能够找出IBS组和IBSt组之间的显著属,如假丁酸弧菌属、梭菌科1和严格梭菌属1。

结论

两种流程在分类学和系统发育多样性上存在差异,Mothur能够获得更多分类学细节,因为每个分类水平的计数数量更高。两种流程均能区分HC组和IBS组中显著富集的属,但Uparse更有能力识别IBS组和IBSt组之间的差异。为了提高可重复性和可靠性,并保持相似研究之间的一致性,考虑不同流程的影响非常重要。

相似文献

1
[Comparison of gut microbiotal compositional analysis of patients with irritable bowel syndrome through different bioinformatics pipelines].[通过不同生物信息学流程对肠易激综合征患者肠道微生物群组成分析的比较]
Beijing Da Xue Xue Bao Yi Xue Ban. 2018 Apr 18;50(2):231-238.
2
A comparison of sequencing platforms and bioinformatics pipelines for compositional analysis of the gut microbiome.用于肠道微生物组组成分析的测序平台和生物信息学管道的比较。
BMC Microbiol. 2017 Sep 13;17(1):194. doi: 10.1186/s12866-017-1101-8.
3
Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.洞察泛微生物组解析中国腹泻型肠易激综合征患者肠道微生物群的特征性失调。
Chin Med J (Engl). 2019 Apr 20;132(8):889-904. doi: 10.1097/CM9.0000000000000192.
4
Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.肠真菌失调和腹泻为主的肠易激综合征患者细菌-真菌相互作用改变:一项探索性研究。
Neurogastroenterol Motil. 2020 Nov;32(11):e13891. doi: 10.1111/nmo.13891. Epub 2020 May 25.
5
Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.腹泻型肠易激综合征患者的粪便和黏膜相关肠道微生物群。
Dig Dis Sci. 2018 Jul;63(7):1890-1899. doi: 10.1007/s10620-018-5086-4. Epub 2018 May 17.
6
Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome.腹泻型肠易激综合征患者肠道微生物群落组成和多样性的改变。
Neurogastroenterol Motil. 2012 Jun;24(6):521-30, e248. doi: 10.1111/j.1365-2982.2012.01891.x. Epub 2012 Feb 20.
7
Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome.粪便细菌可预测利福昔明治疗腹泻型肠易激综合征的疗效。
Pharmacol Res. 2020 Sep;159:104936. doi: 10.1016/j.phrs.2020.104936. Epub 2020 May 26.
8
Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.鉴定与肠易激综合征严重程度相关的肠道微生物群特征。
Gastroenterology. 2017 Jan;152(1):111-123.e8. doi: 10.1053/j.gastro.2016.09.049. Epub 2016 Oct 7.
9
Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome.利福昔明治疗对肠易激综合征相关粪便微生物组和代谢组差异的有限长期影响。
Gut Microbes. 2016 Sep 2;7(5):397-413. doi: 10.1080/19490976.2016.1215805. Epub 2016 Jul 26.
10
Involvement of shared mucosal-associated microbiota in the duodenum and rectum in diarrhea-predominant irritable bowel syndrome.共享黏膜相关微生物群在腹泻为主的肠易激综合征的十二指肠和直肠中的作用。
J Gastroenterol Hepatol. 2018 Jun;33(6):1220-1226. doi: 10.1111/jgh.14059. Epub 2018 Feb 26.